» Articles » PMID: 21373639

Age-specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-based Estimation

Overview
Journal PLoS One
Date 2011 Mar 5
PMID 21373639
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenza in England during the second wave using sera taken between September 2009 and February 2010 in four age groups (1-4, 5-14, 15-24, 25-44 years). The highest cumulative incidence was in 5-14 year olds (59%, 95% credible interval (CI): 52%, 68%) followed by 1-4 year olds (49%, 95% CI: 38%, 61%), rates 20 and 40 times higher respectively than estimated from clinical surveillance. The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period.

Citing Articles

Influenza and other respiratory viral infections associated with absence from school among schoolchildren in Pittsburgh, Pennsylvania, USA: a cohort study.

Read J, Zimmer S, Vukotich Jr C, Schweizer M, Galloway D, Lingle C BMC Infect Dis. 2021; 21(1):291.

PMID: 33752625 PMC: 7983083. DOI: 10.1186/s12879-021-05922-1.


Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis.

Hodgson D, Pebody R, Panovska-Griffiths J, Baguelin M, Atkins K BMC Med. 2020; 18(1):348.

PMID: 33203423 PMC: 7672821. DOI: 10.1186/s12916-020-01802-8.


Seasonal influenza: Modelling approaches to capture immunity propagation.

Hill E, Petrou S, de Lusignan S, Yonova I, Keeling M PLoS Comput Biol. 2019; 15(10):e1007096.

PMID: 31658250 PMC: 6837557. DOI: 10.1371/journal.pcbi.1007096.


Real-time estimation of the influenza-associated excess mortality in Hong Kong.

Wong J, Goldstein E, Fang V, Cowling B, Wu P Epidemiol Infect. 2019; 147:e217.

PMID: 31364545 PMC: 6627011. DOI: 10.1017/S0950268819001067.


The impact of stratified immunity on the transmission dynamics of influenza.

Yuan H, Baguelin M, Kwok K, Arinaminpathy N, van Leeuwen E, Riley S Epidemics. 2017; 20:84-93.

PMID: 28395850 PMC: 5628170. DOI: 10.1016/j.epidem.2017.03.003.


References
1.
Ong J, Chen M, Cook A, Lee H, Lee V, Pin Lin R . Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore. PLoS One. 2010; 5(4):e10036. PMC: 2854682. DOI: 10.1371/journal.pone.0010036. View

2.
Baguelin M, van Hoek A, Jit M, Flasche S, White P, Edmunds W . Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine. 2010; 28(12):2370-84. DOI: 10.1016/j.vaccine.2010.01.002. View

3.
Clark T, Pareek M, Hoschler K, Dillon H, Nicholson K, Groth N . Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009; 361(25):2424-35. DOI: 10.1056/NEJMoa0907650. View

4.
Presanis A, De Angelis D, Hagy A, Reed C, Riley S, Cooper B . The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 2009; 6(12):e1000207. PMC: 2784967. DOI: 10.1371/journal.pmed.1000207. View

5.
Garske T, Legrand J, Donnelly C, Ward H, Cauchemez S, Fraser C . Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ. 2009; 339:b2840. DOI: 10.1136/bmj.b2840. View